Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Ocvirk, P."'
Publikováno v:
Radiology and Oncology, Vol 58, Iss 2, Pp 214-220 (2024)
Transarterial chemoembolisation with irinotecan-loaded drug-eluting beads (DEBIRI TACE) can be considered in patients with unresectable colorectal cancer liver metastases (CRLM) who progress after all approved standard therapies or in patients unsuit
Externí odkaz:
https://doaj.org/article/234bff306e6e41d1aaf73f9701941a95
Publikováno v:
Radiology and Oncology, Vol 57, Iss 1, Pp 103-110 (2023)
We preformed a Phase IV non-interventional study to assess KRAS, NRAS and BRAF status in metastatic colorectal cancer (mCRC) patients suitable for 1st line treatment and to evaluate the decisions for 1st line treatment considering the treatment goals
Externí odkaz:
https://doaj.org/article/994aebd1ea284397a3baf7b4d27035c7
Publikováno v:
Radiology and Oncology, Vol 55, Iss 3, Pp 354-361 (2021)
Immunotherapy with CTLA-4 inhibitors and PD1 checkpoint inhibitors has initiated a breakthrough in the treatment and prognosis of patients with metastatic melanoma. The survival of these patients has increased from the expected survival time of less
Externí odkaz:
https://doaj.org/article/935538ab65c84d85baad1fbee27a06ee
Autor:
Hribernik Nezka, Boc Marko, Ocvirk Janja, Knez-Arbeiter Jasna, Mesti Tanja, Ignjatovic Marija, Rebersek Martina
Publikováno v:
Radiology and Oncology, Vol 54, Iss 1, Pp 119-127 (2020)
Based on recent data from clinical trials, the immune checkpoint inhibitor pembrolizumab prolongs survival and has a good toxicity profile in patients with advanced or metastatic melanoma. However, the question remains whether these results are trans
Externí odkaz:
https://doaj.org/article/4d387ba83ed248a1a9d60068708a81d9
Publikováno v:
Radiology and Oncology, Vol 53, Iss 2, Pp 245-255 (2019)
To determine the effects of perioperative treatment of gastric cancer patients, we conducted an analysis with propensity score matched patient groups to determine the role of perioperative chemotherapy in patients after D2 lymphadenectomy.
Externí odkaz:
https://doaj.org/article/38ca62791dd8430e9e2a7d2aa3b8a616
Publikováno v:
Radiology and Oncology, Vol 53, Iss 1, Pp 85-95 (2019)
Histological parameters of primary tumour and nodal metastases are prognostic factors for survival of operable colorectal (CRC) patients, but not predictive for response rate of systemic therapy. KRAS mutations in codons 12 and 13 were first recogniz
Externí odkaz:
https://doaj.org/article/bc66407f0ec24731b6ac36a6000ebbd8
Autor:
Mesti Tanja, Bouchemal Nadia, Banissi Claire, Triba Mohamed N., Marbeuf-Gueye Carole, Cemazar Maja, Moyec Laurence Le, Carpentier Antoine F., Savarin Philippe, Ocvirk Janja
Publikováno v:
Radiology and Oncology, Vol 52, Iss 4, Pp 392-398 (2018)
Malignant gliomas are rapidly growing tumours that extensively invade the brain and have bad prognosis. Our study was performed to assess the metabolic effects of bevacizumab on the glioma cells carrying the IDH1 mutation, a mutation, associated with
Externí odkaz:
https://doaj.org/article/91d1e923e10d41e58ab38e3e0d3da6f9
Autor:
Moltara Maja Ebert, Novakovic Srdjan, Boc Marko, Bucic Marina, Rebersek Martina, Zadnik Vesna, Ocvirk Janja
Publikováno v:
Radiology and Oncology, Vol 52, Iss 3, Pp 289-295 (2018)
BRAF, NRAS and c-KIT mutations are characteristics of tumour tissues that influence on treatment decisions in metastatic melanoma patients. Mutation frequency and their correlation with histological characteristics in Slovenian population have not be
Externí odkaz:
https://doaj.org/article/0f1e37e3af614d74b759208309c43749
Publikováno v:
Radiology and Oncology, Vol 52, Iss 2, Pp 213-219 (2018)
Mitogen-activated protein kinase kinase (MEK) inhibitor cobimetinib and V-raf murine sarcoma viral oncogene homolog B1 (BRAF) inhibitor vemurafenib have significantly improved the prognosis of BRAF-mutated metastatic melanoma. Some ocular symptoms an
Externí odkaz:
https://doaj.org/article/06878a4a89c34a8a8fa70062474ba670
Autor:
Ocvirk Janja, Moltara Maja Ebert, Mesti Tanja, Boc Marko, Rebersek Martina, Volk Neva, Benedik Jernej, Hlebanja Zvezdana
Publikováno v:
Radiology and Oncology, Vol 50, Iss 2, Pp 226-231 (2016)
Metastatic colorectal cancer (mCRC) is mainly a disease of elderly, however, geriatric population is underrepresented in clinical trials. Patient registries represent a tool to assess and follow treatment outcomes in this patient population. The aim
Externí odkaz:
https://doaj.org/article/65a76550d7cd441a89b2b857aadf5433